CD8A and extranodal nasal NK/T cell lymphoma: (181), immunohistochemistry was performed to stratify NKTCL cases into four subgroups, separated according to tumor immune microenvironments, through quantifying the expression of CD68, CD163, CD8 and FoxP3.